To investigate the role of death receptor signaling in MM resistance to immunotherapy, we performed CRISPR-Cas9 based knockout of two candidate genes (FADD and BID) in two independent MM cell lines (AMO1, L363). This evidence concerns the gene BID and Miyoshi myopathy.